Gene Doping: A Review of Performance-Enhancing Genetics

Pediatric Clinics of North America

Volumn 54, Issue 4, 2007, Pages 807-822

  Gaffney, Gary R ^a   Parisotto, Robin ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANABOLIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; ENDORPHIN DERIVATIVE; ENKEPHALIN; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; METANDIENONE; MYOSTATIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYGEN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH HORMONE; RECOMBINANT HUMAN INSULIN; RECOMBINANT SOMATOMEDIN C; RECOMBINANT VASCULOTROPIN; STEROID;

ANALGESIA; ANEMIA; ANGINA PECTORIS; ATHLETE; ATROPHY; DIABETES MELLITUS; DOPING; DRUG DELIVERY SYSTEM; EMBOLISM; ENDURANCE SPORT; ERYTHROCYTOSIS; GENE ACTIVITY; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC ENGINEERING; GENETIC ENHANCEMENT; GROWTH RETARDATION; GYNECOMASTIA; HEMOPHILIA; HUMAN; MICROARRAY ANALYSIS; MONKEY; MOUSE STRAIN; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCULAR DYSTROPHY; NANOTECHNOLOGY; NONHUMAN; PAIN; PHARMACOGENETICS; RAGE; REVIEW; SIDE EFFECT; SKELETAL MUSCLE; THROMBOSIS; UNSPECIFIED SIDE EFFECT;

ANABOLIC AGENTS; DOPING IN SPORTS; GENE THERAPY; GENETIC ENHANCEMENT; HUMANS; MUSCULOSKELETAL PHYSIOLOGY; NERVOUS SYSTEM PHYSIOLOGY;

EID: 34548127656     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.04.004     Document Type: Review

References (37)

1. World Anti-Doping Agency. The 2007 prohibited list: international standard (2006), WADA, Montreal (Canada)
2. Pincock S. Feature: gene doping. Lancet 366 Suppl 1 (2005) S18-S19
3. Haisma H.L., de Hon O., Sollie P., et al. Gene doping (2004), Netherlands Centre for Doping Affairs, The Netherlands
4. McCrory P. Super athletes or gene cheats?. Br J Sports Med 37 (2003) 192-193
5. Sweeney H.L. Gene doping. Sci Am 291 (2004) 62-69
6. Unal M., and Unal D.O. Gene doping in sports. Sports Med 34 6 (2004) 357-362
7. Trent R.J., and Alexander I.E. Gene therapy in sport. Br J Sports Med 40 (2005) 4-5
8. World Anti-Doping Agency. Gene doping. Play true, official publication of the World Anti-Doping Agency 2005;(1):2-6.
9. Parisotto R. Blood sports: the inside dope on drugs in sport (2006), Hardie Grant Books, Prahran (Victoria)
10. Azzazy H.M.E., Mansour M.M.H., and Christenson R.H. Doping in the recombinant era: strategies and counterstrategies. Clin Biochem 38 11 (2005) 959-965
11. Sinn P.L., Sauter S.L., and McCray Jr. P.B. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12 (2005) 1089-1098
12. Svensson E.C., Black H.B., Dugger D.L., et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of replication-defective adenoviral vector. Hum Gene Ther 8 15 (1997) 1797-1806
13. Zhou S., Murphy J.E., Escobedo J.A., et al. Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther 5 5 (1998) 665-670
14. Goa G., Lebherz C., Weiner D.J., et al. Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 103 9 (2004) 3300-3302
15. Lasne F., Martin L., de Ceaurriz J., et al. "Genetic doping" with erythropoietin cDNA in primate muscle is detectable. Mol Ther 10 3 (2004) 409-410
16. Lippi G., and Guidi G.C. Gene manipulation and improvement of athletic performance: new strategies in blood doping. Br J Sports Med 38 (2004) 641
17. Zarember K.A., and Malech H.L. HIF-1α: a master regulator of innate host defense. J Clin Invest 155 (2005) 1702-1704
18. MacArthur D.G., and North K.N. Genes and human elite performance. Hum Genet 116 5 (2005) 331-339
19. Dekany M., Harbula I., Berkes I., et al. The role of insertion allele of angiotensin converting enzyme gene in higher endurance efficiency and some aspects of pathophysiological and drug effects. Curr Med Chem 13 18 (2006) 2119-2126
20. Pitsiladis Y.P., and Scott R. Essay: the makings of the perfect athlete. Lancet 366 Supl 1 (2005) S16-S17
21. Lee S., Barton E.R., Sweeney H.L., et al. Viral expression of insulin-like growth factor-1 enhances muscle hypertrophy in resistance trained rats. J Appl Physiol 96 3 (2004) 1097-1104
22. Bogdanovich S., Krag T.O., Barton E.R., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 6914 (2002) 418-421
23. Schuelke M., Wagner K.R., Stolz L.E., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 26 (2004) 2682-2688
24. Kramer D.K., Ahlsen M., Norrbom J., et al. Human skeletal muscle fibre type variations correlate with PPAR α, PPAR δ and PGC-1 α mRNA. Acta Physiol (Oxf) 189 1 (2007) 207-216
25. Grimaldi P.A. Regulatory role of peroxisome proliferators-activated receptor delta (PPARδ) in muscle metabolism: a new target for metabolic syndrome treatment?. Biochimie 87 1 (2005) 5-8
26. Wang Y.X., Zhang C.L., Yu R.T., et al. Regulation of muscle fiber type and running endurance by PPAR-δ. PLoS Biol 2 (2004) e294
27. Busquets S., Figueras M., Almendro V., et al. Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim Biophys Acta 1760 11 (2006) 1613-1617
28. Evans C.H., Gouze J.N., Gouze E., et al. Osteoarthritis gene therapy. Gene Therapy 11 (2004) 379-389
29. Fainaru-Wada M., and Williams L. Game of shadows (2006), Gotham Books, New York p. 271-5
30. Johnston L.D., O'Malley P.M., and Bachman J.G. Monitoring the future national results on adolescent drug use: overview of key findings, 2005. NIH Publication No. 06-5882 (2006), National Institutes of Health, Washington, DC
31. Calfee R., and Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics 117 (2006) 577-589
32. Pope Jr. H.G., Gruber A.J., Mangweth B., et al. Body image perception among men in three countries. Am J Psychiatry 157 8 (2000) 1297-1301
33. Choi P.Y.L., Pope H.G., and Olivardia R. Muscle dysmorphia: a new syndrome in weightlifters. Br J Sports Med 36 (2002) 375-377
34. Gene Doping for beginners. Staun J. Playthegame. 2006. Available at: http://www.playthegame.org/Home/Knowledge%20Bank/Authors/Jakob%20Staun.aspx. Accessed February 25, 2007.
35. Pincock S. Gene doping at Torino? The scientist. 2007. Available at: http://www.the-scientist.com/news/display/23101. Accessed February 25, 2007.
36. Rankinen T., Perusse L., Rauramaa R., et al. The human gene map for performance and health-related fitness phenotypes: the 2003 update. Med Sci in Sports Exerc 36 9 (2004) 1451-1469
37. Dennis C. Rugby team converts to give gene tests a try. Nature 434 (2005) 260